Zemplar 5 ug/1ml
Zemplar 5 ug/1ml is a medicine authorised by Swissmedic under authorisation number 56312. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 August 2004 and the authorisation is valid without a time limit. ATC code H05BX02 places the medicine in the group Calcium homeostasis.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zemplar 5 ug/1ml, Injektionslösung | B | 09 August 2004 |
| 2 | Zemplar 10 ug/2ml, Injektionslösung | B | 09 August 2004 |
| 3 | Zemplar 2 ug/1ml, Injektionslösung | B | 06 November 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 5 | Durchstechflasche(n) | H05BX02 | 07.05.0. | B |
| 6 | 5 | Durchstechflasche(n) | H05BX02 | 07.05.0. | B |
| 2 | 5 | Durchstechflasche(n) | H05BX02 | 07.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zemplar 5 ug/1ml authorised in Switzerland?
Yes. Zemplar 5 ug/1ml is authorised by Swissmedic under authorisation number 56312, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zemplar 5 ug/1ml have?
Zemplar 5 ug/1ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zemplar 5 ug/1ml?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.